The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

California Sen. Scott Wiener’s SB 40 & SB 41 aim to reduce prescription costs with insulin affordability & PBM reform ...

Robert F. Kennedy, Jr. was confirmed as the next Secretary of the Department of Health and Human Services (HHS) on Thursday morning. Kennedy was confirmed by the Senate in a full floor vote. The ...

Minister of Trade, Industry and Competition minister Parks Tau wants to reduce healthcare costs right now, with the NHI still ...

Robert F. Kennedy — a vaccine critic, obesity-drug skeptic and processed-foods hater — has secured his spot as head of the US Department of Health and Human Services after promising to “Make America ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

Health insurers no longer completely cover two breast cancer drugs for women with metastasised hormone receptive breast cancer because of high costs. Three types of drugs – palbociclib, ribociclib and ...

CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...